Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal disorders caused by sequential accumulation of somatic driver mutations in hematopoietic stem and progenitor cells (HSPCs). MDS is characterized by ineffective hematopoiesis with cytopenia, dysplasia, inflammation, and a varia...
Main Authors: | Ioannis Chanias, Kristina Stojkov, Gregor Th. Stehle, Michael Daskalakis, Helena Simeunovic, Linet Muthoni Njue, Annatina S. Schnegg-Kaufmann, Naomi A. Porret, Ramanjaneyulu Allam, Tata Nageswara Rao, Rudolf Benz, Axel Ruefer, Adrian Schmidt, Marcel Adler, Alicia Rovo, Stefan Balabanov, Georg Stuessi, Ulrike Bacher, Nicolas Bonadies |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3296 |
Similar Items
-
The Social Evolving: Sociogenomics on the Wings of Social Insects
by: Suryanarayanan Sainath
Published: (2019-12-01) -
Recent Progress of Reclassification of the Genus <i>Streptomyces</i>
by: Hisayuki Komaki
Published: (2023-03-01) -
Dried Blood Spot in Laboratory: Directions and Prospects
by: Kristina Malsagova, et al.
Published: (2020-04-01) -
Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
by: Linet Njue, et al.
Published: (2020-07-01) -
When Should We Think of Myelodysplasia or Bone Marrow Failure in a Thrombocytopenic Patient? A Practical Approach to Diagnosis
by: Nicolas Bonadies, et al.
Published: (2021-03-01)